Jingwei Tian Selected Research

salvianolic acid B

8/2013	SMND-309, a novel derivative of salvianolic acid B, protects rat brains ischemia and reperfusion injury by targeting the JAK2/STAT3 pathway.
1/2011	Therapeutic effects of SMND-309, a new metabolite of salvianolic acid B, on experimental liver fibrosis.
4/2010	Cardioprotective effect of SMND-309, a novel derivate of salvianolic acid B on acute myocardial infarction in rats.
8/2009	Protections of SMND-309, a novel derivate of salvianolic acid B, on brain mitochondria contribute to injury amelioration in cerebral ischemia rats.
3/2009	SMND-309, a novel derivate of salvianolic acid B, ameliorates cerebral infarction in rats: characterization and role.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jingwei Tian Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 10/2012
10	Brain Ischemia (Cerebral Ischemia) 03/2014 - 05/2003
8	Body Weight (Weight, Body) 06/2021 - 06/2013
8	Myocardial Infarction 06/2018 - 02/2010
8	Infarction (Infarctions) 01/2017 - 05/2003
6	Ischemia 06/2014 - 03/2009
4	Neuralgia (Stump Neuralgia) 10/2021 - 01/2018
4	Cocaine-Related Disorders (Cocaine Addiction) 01/2021 - 03/2018
4	Necrosis 02/2020 - 04/2010
4	Fibrosis (Cirrhosis) 06/2018 - 05/2012
4	Myocardial Ischemia (Ischemic Heart Diseases) 05/2012 - 02/2010
3	Memory Disorders (Memory Loss) 05/2022 - 01/2016
3	Parkinson Disease (Parkinson's Disease) 04/2022 - 02/2013
3	Pain (Aches) 01/2022 - 01/2019
3	Substance-Related Disorders (Drug Abuse) 01/2022 - 03/2018
3	Anhedonia 01/2021 - 11/2013
3	Hypersensitivity (Allergy) 01/2018 - 03/2013
3	Reperfusion Injury 03/2014 - 09/2011
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2014 - 05/2003
2	Brain Diseases (Brain Disorder) 01/2022 - 01/2020
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2020
2	Bacterial Infections (Bacterial Infection) 12/2021 - 08/2021
2	Hyperalgesia 10/2021 - 01/2019
2	Chronic Pain 01/2021 - 01/2018
2	Glioma (Gliomas) 02/2020 - 01/2018
2	Brain Neoplasms (Brain Tumor) 02/2020 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2020 - 09/2017
2	Acquired Immunodeficiency Syndrome (AIDS) 09/2018 - 06/2018
2	Inflammation (Inflammations) 09/2018 - 09/2011
2	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 03/2015
2	Stomach Neoplasms (Stomach Cancer) 07/2016 - 01/2016
2	Foreign Bodies (Foreign Body) 06/2013 - 02/2013
2	Cerebral Infarction 03/2009 - 09/2008

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 01/2022 - 02/2013
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2010
7	EnzymesIBA 02/2020 - 10/2007
7	Neuroprotective AgentsIBA 03/2014 - 05/2003
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 02/2013
6	Therapeutic UsesIBA 01/2016 - 01/2011
5	salvianolic acid BIBA 08/2013 - 03/2009
5	2- (6- (2- carboxyvinyl)- 2,3- dihydroxyphenyl)- 3- (3,4- dihydroxyphenyl)acrylic acidIBA 08/2013 - 03/2009
4	SodiumIBA 03/2014 - 06/2011
4	AntioxidantsIBA 04/2010 - 01/2008
3	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2019
3	Alanine Transaminase (SGPT)IBA 02/2020 - 06/2011
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020 - 09/2017
3	KynurenineIBA 11/2019 - 09/2017
3	Interleukin-2 (IL2)IBA 01/2019 - 10/2012
3	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 01/2018
3	Hydroxyproline (4 Hydroxyproline)IBA 01/2017 - 05/2012
3	Liposomes (Liposome)IBA 01/2014 - 02/2013
3	akebia saponin DIBA 05/2012 - 02/2010
3	TriterpenesIBA 05/2012 - 04/2009
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2011 - 05/2003
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2019
2	LPM4870108IBA 01/2022 - 06/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2014
2	PCC-0105002IBA 10/2021 - 08/2020
2	Formaldehyde (Formol)FDA Link 10/2021 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2021 - 02/2020
2	Cocaine (Cocaine HCl)IBA 01/2021 - 01/2020
2	Caspase 3 (Caspase-3)IBA 01/2020 - 12/2010
2	PCC0208009IBA 01/2020 - 01/2018
2	1- cyclohexyl- 2- (5H- imidazo(5,1- a)isoindol- 5- yl)ethanolIBA 01/2020 - 09/2017
2	LigandsIBA 01/2019 - 01/2018
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 01/2018
2	ocotillolIBA 01/2019 - 01/2013
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019 - 01/2018
2	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 01/2018
2	Tryptophan (L-Tryptophan)FDA Link 01/2018 - 09/2017
2	taxaneIBA 01/2017 - 01/2014
2	p38 Mitogen-Activated Protein KinasesIBA 01/2017 - 09/2016
2	Sorafenib (BAY 43-9006)FDA Link 07/2016 - 01/2014
2	NSK-01105IBA 03/2015 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2014 - 08/2013
2	formononetinIBA 03/2014 - 06/2011
2	cremophorIBA 01/2014 - 02/2013
2	ProlactinIBA 06/2013 - 02/2013
2	Polyglactin 910IBA 06/2013 - 02/2013
2	Ethanol (Ethyl Alcohol)IBA 03/2013 - 02/2013
2	SaponinsIBA 05/2012 - 02/2010
2	Troponin T (Troponin T1)IBA 06/2011 - 02/2010
2	MB Form Creatine KinaseIBA 06/2011 - 02/2010
2	Malondialdehyde (Propanedial)IBA 04/2010 - 02/2010
2	CatalaseIBA 04/2010 - 02/2010
2	Glutathione PeroxidaseIBA 04/2010 - 02/2010
2	Superoxide DismutaseIBA 04/2010 - 02/2010
2	hydroxysafflor yellow AIBA 01/2008 - 05/2003
2	Lipid PeroxidesIBA 03/2007 - 02/2005
2	Free RadicalsIBA 03/2007 - 02/2005
2	triphenyltetrazoliumIBA 02/2005 - 05/2003
1	Sevoflurane (Ultane)FDA LinkGeneric 05/2022
1	Glycerophospholipids (Phosphoglycerides)IBA 05/2022

Therapy/Procedure

4	Therapeutics 01/2021 - 09/2017
4	Immunotherapy 01/2020 - 10/2012
3	Drug Therapy (Chemotherapy) 01/2018 - 09/2017
2	Ligation 01/2019 - 04/2010
2	Oral Administration 01/2019 - 07/2016
2	Intravenous Injections 03/2014 - 03/2009